• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US UNKNOWN HIP FEMORAL HEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US UNKNOWN HIP FEMORAL HEAD Back to Search Results
Catalog Number UNK HIP FEMORAL HEAD
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Limb Fracture (4518); Joint Laxity (4526); Insufficient Information (4580)
Event Date 05/12/2020
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
This complaint is from a literature source.The following literature cite has been reviewed: heaven s, perelgut m, vasarhelyi e, howard j, teeter m, lanting b.Fully hydroxyapatite-coated collared femoral stems in direct anterior versus direct lateral hip arthroplasty.Can j surg.2021 mar 26;64(2):e205-e210.Doi: 10.1503/cjs.000920.Pmid: 33769004; pmcid: pmc8064259.Objective and methods: a retrospective study of 778 hips having received depuy corail fully hydroxyapatite-coated collared femoral stems.The study sought to identify the impact of surgical approach for direct anterior approach (daa) compared to direct lateral approach (dla) on post-op femoral stem subsidence and migration over first two years.The authors hypothesized that daa would result in a greater degree of subsidence.Their results, examinations of radiographs for immediate post-op, year 1, and year 2, identified an average subsidence of 1.88 mm on average for daa, compared to 0.47 mm in the dla cohort.The amount of implant varus tilt was slightly greater in the dla group than in the daa group (0.418° versus 0.176°).Results: no statistically significant differences were observed between the cohorts for any of the measurements described at either follow-up time.Surgical approach does not appear to have significantly affected femoral stem migration patterns.Specific product information was not provided for these hips apart from being depuy corail fully hydroxyapatite-coated collared femoral stems.Femoral heads can be assumed to be depuy devices, but the acetabular constructs are unknown.The specific number of patients who experienced some measure of stem subsidence or varus tilt was not provided.The mean subsidence was ~2mm, and mean tilting in varus was ~0.4°.19 revision surgeries were performed as follows (specific details were not provided in any case): 7: for periprosthetic infection.6: for aseptic femoral stem loosening.4: for periprosthetic femur fracture.2: for recurrent hip joint instability.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary : no device associated with this report was received for examination.This complaint was opened to document complaints derived through a journal article review.Follow-ups were done to try and obtain additional information from the author of the journal article.No further information was received.Device history lot : a manufacturing record evaluation (mre), was not possible because the required lot code was not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN HIP FEMORAL HEAD
Type of Device
HIP FEMORAL HEAD
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
Manufacturer (Section G)
DEPUY ORTHOPAEDICS, INC. 1818910
700 orthopaedic dr.
warsaw IN 46581 0988
Manufacturer Contact
kate karberg
700 orthopaedic dr.
warsaw, IN 46581-0988
3035526892
MDR Report Key14955830
MDR Text Key295482009
Report Number1818910-2022-12596
Device Sequence Number1
Product Code JDI
Combination Product (y/n)N
Reporter Country CodeCA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 07/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK HIP FEMORAL HEAD
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/23/2022
Initial Date FDA Received07/08/2022
Supplement Dates Manufacturer Received08/23/2022
Supplement Dates FDA Received08/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-